Osler hemorrhagic telangiectasia syndrome

Search Trials
Intranasal Bevacizumab for HHT-Related Epistaxis
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
HHT
Intervention(s):
BevacizumabPlacebo (Saline)
Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
Status:
Recruiting
Last Changed:
Dec 9, 2018
First Changed:
Jan 1, 1970
Disease(s):
Pulmonary Arteriovenous Malformations
Intervention(s):
Angiography and embolotherapy
Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Hepatic Encephalopathy
Intervention(s):
Critical flicker frequency assessment
Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction
Status:
Unknown status
Last Changed:
Jan 6, 2015
First Changed:
Jan 6, 2015
Disease(s):
Pulmonary Arteriovenous Malformations
Intervention(s):
Cardiopulmonary exercise test
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status:
Completed
Last Changed:
Feb 8, 2011
First Changed:
Jan 1, 1970
Disease(s):
Arteriovenous Malformation
Intervention(s):
Thalidomide

Connect. Empower. Inspire.